[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100513772":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":17,"centralContacts":22,"locations":27,"responsibleParty":43,"collaborators":45,"id":54,"slug":10,"hasResults":55,"nctId":56,"briefTitle":57,"officialTitle":58,"acronym":59,"eligibilityCriteria":60,"healthyVolunteers":55,"sex":61,"minAge":62,"maxAge":10,"enrollmentInfo":63,"targetDuration":66,"studyType":67,"phases":10,"briefSummary":68,"conditions":69,"keywords":86,"overallStatus":88,"whyStopped":10,"lastUpdateSubmitDate":89,"lastUpdatePostDateStruct":90,"startDateStruct":93,"completionDateStruct":95,"leadSponsor":97,"locationsCount":98},{"fullName":5,"class":6},"Assistance Publique - Hôpitaux de Paris","OTHER",[8],{"label":9,"type":10,"description":9,"interventionNames":11},"Dysimmune manifestations with or without clonal hematopoiesis",null,[12],"Other: observational cohort study",[14],{"type":6,"name":15,"description":15,"armGroupLabels":16,"otherNames":10},"observational cohort study",[9],[18],{"name":19,"affiliation":20,"role":21},"Arsene MEKINIAN, MD PhD","Service de médecine interne, Hôpital Saint Antoine, APHP, Paris","PRINCIPAL_INVESTIGATOR",[23],{"name":19,"role":24,"phone":25,"phoneExt":10,"email":26},"CONTACT","+33149282392","arsene.mekinian@aphp.fr",[28],{"facility":29,"status":10,"city":30,"state":10,"zip":31,"country":32,"cosmosGeoPoint":33,"geoPoint":38,"contacts":39},"AP-HP, Service de médecine interne, Hôpital Saint Antoine","Paris","75012","France",{"type":34,"coordinates":35},"Point",[36,37],2.3488,48.85341,{"lat":37,"lon":36},[40],{"name":41,"role":24,"phone":42,"phoneExt":10,"email":26},"Arsène MEKINIAN, MD PhD","+33 (0)1 49 28 23 92",{"type":44,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[46,48,51],{"name":47,"class":6},"Sorbonne University",{"name":49,"class":50},"Institut National de la Santé Et de la Recherche Médicale, France","OTHER_GOV",{"name":52,"class":53},"Club MINHEMON (MEDECINE INTERNE, HEMATO ET ONCO)","UNKNOWN","100513772",false,"NCT05969821","Clonal Hematopoiesis of Immunological Significance","Immuno-inflammatory Manifestations With or Without Clonal Hematopoiesis: Ambispective Cohort Study","CHIS","Inclusion Criteria:\n\n* Age \\>=18 years old;\n* Confirmed dysimmune manifestations: clinical or biological abnormality or systemic disease;\n* Presence or absence of myeloid or lymphoid blood disease according to World Health Organization (WHO) classification\n\nExclusion Criteria:\n\n* Persons benefiting from special protection: adults under guardianship and curatorship;\n* People hospitalized without their consent and not protected by law; persons deprived of liberty;\n* Persons not affiliated to the social security system","ALL","18 Years",{"count":64,"type":65},5000,"ESTIMATED","10 Years","OBSERVATIONAL","Ambispective, national, multicenter observational cohort study aimed at characterizing the satellite dysimmune manifestations of clonal hematopoiesis, including Vexas (Vacuoles, E1 enzyme, X-linked, Autoinflammatory and Somatic) syndrome.",[70,71,72,73,74,75,76,77,78,79,80,81,82,83,84,85],"Immune System Diseases","Autoimmune Diseases","Inflammation","Autoinflammatory Diseases","Vexas Syndrome","Hematopoiesis Clonal","Clonal Hematopoiesis of Indeterminate Potential","Hematologic Diseases","Myelodysplastic-Myeloproliferative Diseases","Leukemia Myelomonocytic Chronic","Myelodysplastic Syndromes","Myeloproliferative Disorders","Lymphoproliferative Disorders","Lymphoma","Leukemia","Monoclonal Gammopathy of Undetermined Significance",[72,73,87,71,76,78,82,85],"Vexas syndrome","NOT_YET_RECRUITING","2026-03-19",{"date":91,"type":92},"2026-03-23","ACTUAL",{"date":94,"type":65},"2026-04",{"date":96,"type":65},"2045-09",{"name":5,"class":6},1]